2023
DOI: 10.1016/j.ejphar.2023.175875
|View full text |Cite|
|
Sign up to set email alerts
|

Lapatinib ditosylate rescues motor deficits in rotenone-intoxicated rats: Potential repurposing of anti-cancer drug as a disease-modifying agent in Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(2 citation statements)
references
References 92 publications
0
2
0
Order By: Relevance
“…Activates GPX4/GSH/NRF2 axis; inhibits oxidative markers, including iron, TfR1, PTGS2, and 4-HNE; and suppresses p-EGFR/c-SRC/PKCβII/PLC-γ/ACSL-4 pathway [119].…”
Section: Lapatinibmentioning
confidence: 99%
“…Activates GPX4/GSH/NRF2 axis; inhibits oxidative markers, including iron, TfR1, PTGS2, and 4-HNE; and suppresses p-EGFR/c-SRC/PKCβII/PLC-γ/ACSL-4 pathway [119].…”
Section: Lapatinibmentioning
confidence: 99%
“…Furthermore, lapatinib had an impact on proteins such as LRKK2, α-syn, and c-ABL, resulting in the restoration of dopamine levels as well as the suppression of ferroptosis and lipid peroxidation. This study highlights the potential of targeting the HSP90/CDC37 complex to activate the antioxidant system [177], although it is crucial to consider its possible impact on glutathione (GSH) levels, which also play a role in PD pathogenesis [178].…”
Section: Pharmacological Modulation Of Hsps and Neuroprotective Effec...mentioning
confidence: 99%